US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Theraclion (THEBS) 銘柄情報

Theraclion (THEBS)

0.12

0.02

(20.00%)

終了 6月6日 12:30AM

Theraclion (THEBS) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.12

( 20.00% )

買値

0.10

売値

0.125

出来高

14,743

0.101 日の範囲 0.12

0.10 52 週間の範囲 0.12

時価総額

前日終値

0.10

始値

0.101

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

115,643 €

発行済株式数

73,108,471

配当利回り

PER

-7.46

1 株当たり利益 (EPS)

-0.1

歳入

652k

純利益

-5.69M

Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposab... Theraclion SA provides therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient’s skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.theraclion.com

本社

Malakoff, France

設立

2026

Theraclion is listed in the sector of the ユーロネクスト with ticker THEBS. The last closing price for Theraclion was 0.10 €. Over the last year, Theraclion shares have traded in a share price range of 0.10 € to 0.12 €.

Theraclion currently has 73,108,471 shares in issue. The market capitalisation of Theraclion is 8.77 € million. Theraclion has a price to earnings ratio (PE ratio) of -7.46.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.01	9.09090909091	0.11	0.12	0.1	4694	0.10780213	DE
4	0.01	9.09090909091	0.11	0.12	0.1	4694	0.10780213	DE
12	0.01	9.09090909091	0.11	0.12	0.1	4694	0.10780213	DE
26	0.01	9.09090909091	0.11	0.12	0.1	4694	0.10780213	DE
52	0.01	9.09090909091	0.11	0.12	0.1	4694	0.10780213	DE
156	0.01	9.09090909091	0.11	0.12	0.1	4694	0.10780213	DE
260	0.01	9.09090909091	0.11	0.12	0.1	4694	0.10780213	DE

THEBS - Frequently Asked Questions (FAQ)

What is the current Theraclion share price?

The current share price of Theraclion is 0.12 €

How many Theraclion shares are in issue?

Theraclion has 73,108,471 shares in issue

What is the market cap of Theraclion?

The market capitalisation of Theraclion is EUR 8.77M

What is the 1 year trading range for Theraclion share price?

Theraclion has traded in the range of 0.10 € to 0.12 € during the past year

What is the PE ratio of Theraclion?

The price to earnings ratio of Theraclion is -7.46

What is the cash to sales ratio of Theraclion?

The cash to sales ratio of Theraclion is 79.61

What is the registered address of Theraclion?

The registered address for Theraclion is 244, avenue Pierre Brossolette, Malakoff, Ile-de-France, 92240

What is the Theraclion website address?

The website address for Theraclion is www.theraclion.com

hardlesson

hardlesson 5分前

You're one of the hardest working guys on ihub. Banging out the charts on a Saturday morning. Thanks always, and have a good weekend. :)

Investor082

Investor082 5分前

LP will be back there again in a couple years still pleading for a change (pathway act) so she can submit regulatory application to FDA in 2030, LOL! ;)

WhiteOwl

WhiteOwl 6分前

Am I missing something or does that Video say everything is experimental or just theory? I was under the impression they had perfected a workable unit? Just saying.

THE OLD OWL 🦉🦉🦉

glenn1919

glenn1919 9分前

BCDA......BMGL.......BGMS......ACCL......CMND.........CGTL...........https://stockcharts.com/sc3/ui/?s=CMND&p=w&yr=1&mn=3&dy=0&id=p96837884856

Investor082

Investor082 10分前

No excuses when LP disappoints on this, OK?

I will check in on this message whenever there is a decision, LOL! ;)

WhenLambo

WhenLambo 10分前

FIFA is already on public record marketing them, what could be bigger than that? They’ll continue to put VuMe out there next week

train21

train21 12分前

DRIVEN IS BACK
so I guess we going to see 5 cents again ? well are we ?

Investor082

Investor082 13分前

Don't let LP and her toxic financiers screw you year after year, LOL! ;)

Instead invest in well known AI and tech stocks run by solid management crew.

glenn1919

glenn1919 14分前

STAK......SPHL.....SMTK......SAOR.....SNBR.......SCAG.....SPPL..................................https://stockcharts.com/sc3/ui/?s=SCAG&p=w&yr=1&mn=3&dy=0&id=p96837884856

jackinthegreen

jackinthegreen 14分前

Exactly - another round of press and hype can drive the price up a bit, but without substantial new contracts and revenue outside the consumer electronics space, it will only be a temporary bump. We’ve been here before - buying on the rumor is great, but what we need is actual profitability.

train21

train21 14分前

BOTH CEOs BLOCKED ME ON X
I MUST HAVE HIT THE NAIL ON THE HEAD
ANY CEO THAT BLOCKS QUESTIONS OF THEIR DECISIONS IS HIDING SOMETHING BIG AND BAD ???

rodman

rodman 15分前

There appears to be some life left in UEEC based upon the buying and pps increase this week.

cottonmather

cottonmather 15分前

Drey Dossier. The WH Ballroom ain't what it used to be. 17 minutes https://youtu.be/VbJ4ilDvGyc?si=DispyZYqLVQNJyms

USAFpatriot

USAFpatriot 15分前

Annual meeting 8k.

https://investorshub.advfn.com/stock-market/NASDAQ/novocure-NVCR/stock-news/98686681/form-8-k-current-report

train21

train21 16分前

$GTVH YOU ALL NEED TO FILE COMPLAINTS ON THE $OTC WEB SITE AND THE $FINRA WEB SITE
I CAN NOT JUST BE THE ONLY ONE FILING COMPLAINTS HERE ? SOME OF YOU GUYS LOST THOUSANDS $$$$$
CASEY IS A SHARE SELLING SCAMMMER AND MEDIA POSTING LIAR ......... AND THATS ALL THIS STOCK IS

HGiLS

Absolutely — let’s build the full, structured deep-dive you asked for. Below is everything:

• All Eliquis ANDA filers
• Their litigation outcomes
• Each filer’s non-infringement arguments
• Why none succeeded
• Drugs where generics did win using alternative

peafunke

peafunke 19分前

You told ‘who’ so? The fifa concerts are this coming week.

HGiLS

Yes — Eliquis (apixaban) has exactly the kind of ANDA litigation you’re asking about: cases where a generic filer challenged the Orange Book patents and argued non-infringement because their own formulation or manufacturing approach did not fall within the scope of the listed patents.

Teddytropics

Teddytropics 21分前

I will leave it up to you to decide..

I ask myself.. why is this guy so obsessed with Jason Black..?

That he wants to 'to tell on Jason Black' to all..

Where Jason Black isn't involved here anymore except for the CNNA OTC page still listing him..

Big Hook

Big Hook 22分前

I told you so! There is no more time left to do anything with FIFA or concerts . To get the views they needed to do major marketing. They did nothing. Just stringing the few people in here along. Another complete failure from the clown ST3.

train21

train21 22分前

$STEK LETS GO HERE TIME FOR A RUN UP
SHARES ARE CHEAP ENOUGH ?

train21

train21 23分前

$vhai waiting on the new CEO to get off the phone and do his job

StockGuy2026

StockGuy2026 24分前

Nvidia has certified Micron alongside South Korea’s SK Hynix and Samsung Electronics as providers of the latest design of high-bandwidth memory, known as HBM4, Nvidia CEO Jensen Huang said on Friday.

Overall, as HBM generations continue evolving in 2027, with larger die sizes and simu

Longstrongsilver

Longstrongsilver 24分前

lol well that’s a bruised knee post if we’ve ever seen one. I bet this ages as good as many of your other posts (read not well). You’d best hope he or someone buys up the whole float because the abysmal volume here shows paper longs certainly aren’t buying much of it even at these “cheapies “ price

fricassee

fricassee 25分前

I think this might be how Liquidmetal trades in the future, at least for a while, without any contracts. A person who's never heard of Liquidmetal suddenly finds the name rumored by Apple. He's looking forward to buying a new iPhone in September, and he's reading about the new Apple Fold and the cre

Graphic Packaging

AB Emerging Markets Oppo...

Brookfield Renewable

Verity Resources

Ohio Valley Banc

Ecora Royalties

ScanTech AI Systems (PK)

Amundi EUR Corp Bond ESG...

Aeva Technologies

Brookfield Renewable

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。